ROCHESTER, N.Y., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Transcat, Inc. (Nasdaq: TRNS ) ("Transcat" or the "Company"), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that Lee D. Rudow, President and Chief Executive Officer, and John J. Zimmer, Senior Vice President of Finance and Chief Financial Officer, will present to institutional investors and analysts at the 2014 Western New York Investors Conference on Friday, September 26, 2014 in Buffalo, New York.
Transcat's presentation is scheduled to begin at 9:45 a.m. ET. A live webcast of the presentation, along with presentation materials, will be available on the Company's website at www.transcat.com . The webcast link will also be available on the conference website at www.wnyinvest.org . If you are unable to listen to the live presentation, an archive will be available on both websites.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration and compliance services including analytical instrument qualifications, equipment and process validation. Targeted industries include life science, biotechnology, medical device, pharmaceutical and other FDA-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Throughout its 18 strategically located centers of excellence in the United States, Canada and Puerto Rico, Transcat delivers precise services with reliable turn-around times. The breadth and depth of measurement parameters addressed by Transcat's ISO/IEC 17025 scopes of accreditation are believed to be among the best in the industry.
In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. Through its Distribution segment, Transcat markets and distributes premier and propriety brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test, measurement and control products.
Transcat's growth strategy is to expand its service and distribution platform comprised of a balanced suite of test products and analytical, calibration, compliance, and validation services. The goal is to deliver specialized technical services with a quality assurance approach, which maximizes document accuracy and on-time job delivery. Transcat answers the call with cGMP, GLP, and GXP compliant services. Transcat can provide life science companies with a reliable alternative service and product solution to the OEMs and to the "generalist" service providers who cannot meet the client's specialized needs.
More information about Transcat can be found on its website at: Transcat.com .
For more information contact: John J. Zimmer, Chief Financial Officer Phone: (585) 352-7777 Email: Deborah K. Pawlowski, Investor Relations Kei Advisors LLC Phone: (716) 843-3908 Email:
